Skip to main content
Premium Trial:

Request an Annual Quote

Viaken Partners with InforSense to Market Datamining and Visualization Platform

NEW YORK, July 23 - Viaken has partnered with e-science platform provider InforSense to market and distribute their large-scale genomic analysis and drug discovery platform, the companies announced Monday.

The platform, called the Kensington Discovery Edition, was developed by Copenhagen-based InforSense as networked-based software for data mining and analysis.

Terms of the agreement were not disclosed.

"The Kensington system provides the type of high-end enterprise scale data mining and visualization system that is required to manage and interpret the large volumes of complex data that are generated by today's drug discovery processes," Steve Gardner, chief technical officer of Viaken, said in a statement. "Kensington enables researchers to make more rapid and accurate decisions about R&D projects using a full range of statistical analysis and data mining tools."

Viaken, of Gaithersburg, Md, resells and hosts bioinformatics software applications, providing IT bioinformatics support to customers around the world. Unlike other genomics-related internet hubs, including those offered by DoubleTwist, Compugen, and eBioinformatics, Viaken does not develop proprietary software or content. 

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.